ADAM10 membrane-bound protease mediates malignant pleural mesothelioma invasiveness

C. Sepult (Liege, Belgium), M. Bellefroid (Liege, Belgium), C. Gilles (Liege, Belgium), A. Ludwig (Aachen, Germany), B. Duysinx (Liege, Belgium), A. Noel (Liege, Belgium), D. Cataldo (Liege, Belgium)

Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management
Session: Mesothelioma and pleural malignancy: investigations and management
Session type: Thematic Poster
Number: 2865
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Sepult (Liege, Belgium), M. Bellefroid (Liege, Belgium), C. Gilles (Liege, Belgium), A. Ludwig (Aachen, Germany), B. Duysinx (Liege, Belgium), A. Noel (Liege, Belgium), D. Cataldo (Liege, Belgium). ADAM10 membrane-bound protease mediates malignant pleural mesothelioma invasiveness. 2865

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Aminopeptidase N/CD13 as a potential therapeutic target in malignant pleural mesothelioma
Source: Eur Respir J, 51 (5) 1701610; 10.1183/13993003.01610-2017
Year: 2018



CXCL12 expression in malignant mesothelioma
Source: Eur Respir J 2007; 30: Suppl. 51, 138s
Year: 2007

Soluble mesothelin-related peptides in the diagnosis of malignant pleural mesothelioma
Source: Annual Congress 2008 - Inorganic dust exposure and the lung
Year: 2008


Talc mediates angiostasis in malignant pleural effusions via endostatin induction
Source: Eur Respir J 2007; 29: 761-769
Year: 2007



All-trans-retinoic acid inhibits tumour growth of malignant pleural mesothelioma in mice
Source: Eur Respir J 2009; 34: 1159-1167
Year: 2009



Host-derived osteopontin is important for malignant pleural effusion formation
Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases
Year: 2008


RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer
Source: Eur Respir J 2012; 39: 677-684
Year: 2012



Clinical role of pleural effusion MMP-3 levels in malignant pleural mesothelioma
Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions
Year: 2012

Forced chemokine ligand 2 overexpression renders melanoma cells capable of inducing experimental malignant pleural effusion
Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases
Year: 2008

Targeting of CSF1R abrogates Lewis Lung adenocarcinoma-induced malignant pleural effusion
Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management
Year: 2018

A novel clinical role for angiopoietin-1 in malignant pleural mesothelioma
Source: Eur Respir J 2010; 36: 1099-1105
Year: 2010



Comparison of telomerase activity in malignant and benign pleural effusions
Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura
Year: 2011

All-trans-retinoic acid inhibits tumor growth of malignant pleural mesothelioma in mice
Source: Annual Congress 2010 - Basic mechanisms in malignant pleural disease biology
Year: 2010



Malignant pleural effusion cells show aberrant glucose metabolism gene expression
Source: Eur Respir J 2011; 37: 1453-1465
Year: 2011



Proliferation controlling intercellular signalling pathways in human pleural malignant mesothelioma
Source: Annual Congress 2007 - Pleural malignancy
Year: 2007



Novel Synthetic lignan reduces asbestos-induced damage in human pleural mesothelial cells-Potential clinical usefulness in inhibiting pleural malignant mesothelioma
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017


mTOR inhibition blocks tumor growth and pleural fluid accumulation in experimental murine mesothelioma
Source: Annual Congress 2011 - Treatment options and tumour biology of malignant pleural mesothelioma
Year: 2011

Osteopontin is important for malignant pleural effusion formation
Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Year: 2009

Alteration of neutrophil invasion toward malignant mesothelioma by Interleukin-10
Source: Eur Respir J 2002; 20: Suppl. 38, 231s
Year: 2002

The inhibitory effect of PI3k inhibitor and MEK inhibitor on malignant pleural mesothelioma cell growth
Source: Annual Congress 2009 - Pleural and mediastinal diseases
Year: 2009